Achilles Therapeutics (ACHL) Q3 2023 Earnings

Nov 13Confirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.61
-0.54
-0.47
-0.4

Details

Expected EPS
-0.4
Actual EPS
-0.42
Surprise EPS
-0.02
Surprise Percent
-5%

Description

⁨Achilles Therapeutics⁩ (⁦ACHL⁩) has reported earnings of ⁦-0.42⁩ per share for ⁦Q3 2023⁩.

0 Comments

Share your thoughts